CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 214 enrolled
Drug / intervention
AZD8529drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02401022
NCT02401022Phase 2Completed
CompareCT.gov

The Study of AZD8529 for Smoking Cessation in Female Smokers

National Institute on Drug Abuse (NIDA)·interventional·Posted Mar 27, 2015·Updated Nov 29, 2017

In Brief

A Phase 2 clinical trial evaluating AZD8529 for Tobacco Use Disorder. Completed, enrolled 214 participants across 9 sites.

Detailed Summary

To evaluate the efficacy and safety of AZD8529 for smoking cessation in female smokers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTobacco Use Disorder
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 27, 2015
Enrollment StartJul 1, 2015
Primary CompletionNov 1, 2016
Study CompletionJan 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 11.3 years ago

Interventions

AZD8529drug

comparison of different dosages of drug